Arovella Therapeutics LimitedASX: ALA

Arovella licences novel monoclonal antibody from MD Anderson

Dec 13, 2021 at 3:49 AM UTC · Issued by Arovella Therapeutics Limited

Arovella Therapeutics Ltd has released a press release.

View Attachment